Covalon Technologies Ltd V.COV

Alternate Symbol(s): CVALF

Healthcare Biotechnology

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.

TSXV:COV - Post by User

Covalon Technologies Ltd

Bullboard Posts

Post by TheMonolithon Aug 20, 2018 1:34pm

162 Views

Post# 28487553

Licensing deal a big deal

This has long been a goal for Covalon and we know that they have had some dealings in R&D with J&J and Boston Scientific. It's major news that someone finally pulled the trigger in the implanted device market. The licensing revenue could be monstrous.

More confirmation that Brian and the BOD's opinion that they will be worth $1 Billion is a realistic goal.

Park your shares in a retirement account and forget about it.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!